QGEN
Qiagen NV

1,396
Mkt Cap
$10.69B
Volume
768,460.00
52W High
$51.88
52W Low
$37.63
PE Ratio
28.88
QGEN Fundamentals
Price
$49.35
Prev Close
$48.60
Open
$48.89
50D MA
$47.04
Beta
0.60
Avg. Volume
1.22M
EPS (Annual)
$0.3826
P/B
3.05
Rev/Employee
$343,142.06
Loading...
Loading...
News
all
press releases
PacBio Aims to Expand Multiomic Capabilities Via Latest Innovations
PACB unveils new SPRQ-Nx chemistry to cut sequencing costs and boost multiomic features on Revio and Vega.
Zacks·4d ago
News Placeholder
More News
News Placeholder
Will Positive Regulatory Updates Further Boost INCY Stock?
Incyte's strong 2025 performance is fueled by Jakafi's sustained growth and label expansion of Opzelura.
Zacks·4d ago
News Placeholder
QIAGEN N.V. to Release Results for Q3 2025 and Hold Webcast
QIAGEN N.V. (NYSE: QGEN) (Frankfurt Stock Exchange: QIA) today announced plans to release results for the third quarter of 2025. Press release date / time: Tuesday, November 4, shortly after 22:05...
Business Wire·11d ago
News Placeholder
Oculis Holding AG (OCS) Soars 6.3%: Is Further Upside Left in the Stock?
Oculis Holding AG (OCS) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Zacks·14d ago
News Placeholder
QGEN vs. ACAD: Which Stock Is the Better Value Option?
QGEN vs. ACAD: Which Stock Is the Better Value Option?
Zacks·15d ago
News Placeholder
Hologic Expands Panther Fusion's Menu With Diagnostic Innovation
HOLX expands its Panther Fusion platform with new GI bacterial assays, securing FDA and EU approvals to boost Diagnostics growth.
Zacks·16d ago
News Placeholder
How to Play HOLX Stock This Breast Cancer Awareness Month?
Hologic's breast health innovations, AI breakthroughs and leadership moves signal optimism ahead despite macro headwinds.
Zacks·18d ago
News Placeholder
Illumina to Join Pharma Partners for CDx Development on KRAS Biomarker
ILMN partners with pharma leaders to advance KRAS-focused companion diagnostics through its TruSight Oncology platform.
Zacks·22d ago
News Placeholder
Quest Diagnostics Joins Forces With Epic to Improve Laboratory Testing
DGX teams up with Epic on Project Nova to streamline lab testing, boost efficiency, and enhance patient and provider experiences.
Zacks·23d ago
News Placeholder
PacBio Enters Carrier Screening Market With PureTarget Expansion
PACB expands its PureTarget portfolio, streamlining carrier screening with HiFi sequencing to meet rising global demand.
Zacks·24d ago

Latest QGEN News

View

Advertisement|Remove ads.

Advertisement|Remove ads.